Luan Y, Liang C, Han Q, Zhou X, et al. The systematic analysis of genes related to butyrate metabolism suggests that CDKN3 could serve as a promising therapeutic target for lung adenocarcinoma treatment. BMC Cancer 2025;25:69.
PMID: 39806313